SERA LABORATORIES INTERNATIONAL LIMITEDActive
Key figures
SERA LABORATORIES INTERNATIONAL LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024Balance sheet structure
Filed accounts2022–2024
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Profit for the year | 2,933,578 | 3,257,111 | 3,549,425 |
| Cash at bank and in hand | 813,245 | 791,857 | 682,377 |
| Total assets | 44,910,684 | 49,671,384 | 91,918,926 |
| Total liabilities | 19,822,921 | 21,334,744 | 27,190,888 |
| Net assets / total equity | 25,060,616 | 28,317,727 | 64,725,692 |
| Average number of employees | 36 | 44 | 52 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024The principal activity of the Company and Group is to enable and accelerate medical breakthroughs that enhance and extend lives by delivering personalised biospecimen solutions to the life science and diagnostics industries.
As described in the company's latest filed accounts.
Summary: SERA LABORATORIES INTERNATIONAL LIMITED
Company
SERA LABORATORIES INTERNATIONAL LIMITED is a private limited company registered with Companies House under company number 03572986. It was incorporated on 1 Jun 1998. Its status is active. The registered office is in London (EC3A). Its nature of business (SIC 2007) is non-specialised wholesale trade (46900).
Accounts
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files group accounts. Profit for the year was £3,549,425. Net assets were £64,725,692, up 128.6% on the previous year. Cash at bank and in hand was £682,377. Total assets were £91,918,926 and total liabilities £27,190,888. The company had an average of 52 employees. Figures are available for 3 financial years (2022–2024).
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 29 Jun 2027.